UPDATED Jun 12, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRK | US$81.82 | 1.9% | -36.8% | US$201.7b | US$101.79 | PE11.8x | E7.5% | 4.0% | ||
GILD | US$112.05 | 2.5% | 72.2% | US$139.4b | US$116.00 | PE23.4x | E10.6% | 2.8% | ||
JNJ | US$156.66 | 0.9% | 7.7% | US$373.6b | US$169.18 | PE17.3x | E1.1% | 3.3% | ||
LLY | US$812.03 | 0.4% | -8.1% | US$725.9b | US$951.98 | PE65.6x | E22.4% | 0.7% | ||
AMGN | US$297.29 | 1.9% | -0.4% | US$156.9b | US$314.70 | PE26.9x | E12.1% | 3.2% | ||
PFE | US$24.84 | 1.5% | -10.2% | US$139.2b | US$29.24 | PE18x | E7.2% | 6.9% | ||
VRTX | US$460.06 | 1.7% | -4.0% | US$116.2b | US$500.12 | PS10.6x | E31.1% | n/a | ||
ONC | US$276.53 | 5.4% | 66.2% | US$33.4b | US$331.97 | PS8.4x | E52.5% | n/a | ||
ABBV | US$192.42 | 0.5% | 15.5% | US$338.3b | US$208.86 | PE81.8x | E26.2% | 3.4% | ||
ZTS | US$168.82 | 1.5% | -1.5% | US$74.1b | US$195.37 | PE29.8x | E7.3% | 1.2% | ||
BMY | US$50.69 | 1.1% | 22.2% | US$102.1b | US$57.10 | PE19x | E7.6% | 4.9% | ||
ALNY | US$304.67 | 2.0% | 90.4% | US$38.9b | US$320.88 | PS16.9x | E60.7% | n/a | ||
RPRX | US$35.27 | 3.6% | 29.7% | US$19.1b | US$41.52 | PE13.6x | E5.8% | 2.5% | ||
TEVA | US$17.71 | 2.3% | 1.8% | US$19.9b | US$23.56 | PS1.2x | E57.5% | 0% | ||
UTHR | US$286.14 | 3.5% | -0.5% | US$12.5b | US$382.09 | PE10.7x | E6.7% | n/a | ||
SMMT | US$20.16 | 3.0% | 149.2% | US$14.5b | US$34.82 | PB43.5x | E38.1% | n/a | ||
CVAC | US$5.60 | 37.6% | 40.0% | US$916.4m | US$6.49 | PE6x | E-30.3% | n/a | ||
REGN | US$521.84 | 0.6% | -49.2% | US$54.8b | US$727.21 | PE12.3x | E6.8% | 0.7% | ||
DHR | US$205.10 | 0.2% | -19.6% | US$146.5b | US$247.14 | PE39x | E12.9% | 0.6% | ||
LEGN | US$37.91 | 3.6% | -13.2% | US$6.7b | US$76.42 | PS9.6x | E58.0% | n/a | ||
LIMN | US$20.31 | 82.8% | 82.5% | US$289.0m | n/a | PE-149x | n/a | n/a | ||
VRNA | US$92.50 | 2.7% | 494.4% | US$8.2b | US$97.10 | PS71.1x | E54.4% | n/a | ||
WAT | US$349.57 | 1.0% | 18.3% | US$20.6b | US$387.57 | PE31.7x | E8.6% | n/a | ||
ZLAB | US$43.03 | 3.9% | 118.5% | US$4.5b | US$55.39 | PS11.2x | E64.1% | n/a |